_
´
J. Zabinski et al. / Journal of Molecular Structure 984 (2010) 68–74
74
[5] C.E. Stephens, F. Tanious, S. Kim, W.D. Wilson, W.A. Schell, J.R. Perfect, S.G.
Franzblau, D.W. Boykin, J. Med. Chem. 44 (2001) 1741–1748.
[6] I.J. Simpson, M. Lee, A. Kumar, D.W. Boykin, S. Neidle, Bioorg. Med. Chem. Lett.
10 (2000) 2593–2597.
the presence of two the NH2 groups in each amidine substituent,
which differ due to slight deviation of amidine substituent from
the benzene ring plane. This statement is in good agreement with
the theoretical conformation showed in the top of Fig. 5.
[7] D.W. Boykin, J. Braz. Chem. Soc. 13 (2002) 763–771.
[8] B.S.P. Reddy, S.M. Sondhi, J.W. Lown, Pharmacol. Therap. 84 (1999) 1–111.
[9] K.J. Edwards, T.C. Jenkins, S. Neidle, Biochemistry 31 (1992) 7104–
7109.
4. Conclusions
[10] T.V. Hughes, S.L. Emanuel, A.K. Beck, S.K. Wetter, P.J. Connolly, P. Karnachi, M.
Reuman, J. Seraj, A.R. Fuentes-Pesquera, R.H. Gruninger, S.A. Middleton, R. Lin,
J.M. Davis, D.F.C. Moffat, Bioorg. Med. Chem. Lett. 17 (2007) 3266–3270.
[11] U.H. Olesen, M.K. Chrisensen, F. Bjorkling, M. Jaattela, P.B. Jensen, M. Sehested,
S.J. Nielsen, Biochem. Biophys. Res. Commun. 367 (2008) 799–804.
[12] R.T. Berendt, D.M. Sperger, P.K. Isbester, E.J. Munson, Trends in Anal. Chem. 25
(2006) 977–984.
[13] M. Geppi, G. Mollica, S. Borsacchi, C.A. Veracini, Apl. Spectr. Rev. 43 (2008)
202–302.
[14] Oxford Diffraction Poland, CrysAlisCCD, CCD Data Collection GUI, Version
1.171.31.5, 2006.
[15] Oxford Diffraction Poland, CrysAlisRED, CCD Data Reduction GUI, Version
1.171.31.5, 2006.
[16] G.M. Sheldrick, Acta Crystallogr. A46 (1990) 467–473.
[17] G.M. Sheldrick, SHELXL97, Program for the Refinement of Crystal Structures,
University of Göttingen, Germany, 1997.
[18] Gaussian 03, Revision B.02, M.J. Frisch, G.W. Trucks, H.B. Schlegel, G.E.
Scuseria, M.A. Robb, J.R. Cheeseman, J.A. Montgomery, Jr., T. Vreven, K.N.
Kudin, J.C. Burant, J.M. Millam, S.S. Iyengar, J. Tomasi, V. Barone, B. Mennucci,
M. Cossi, G. Scalmani, N. Rega, G.A. Petersson, H. Nakatsuji, M. Hada, M. Ehara,
K. Toyota, R. Fukuda, J. Hasegawa, M. Ishida, T. Nakajima, Y. Honda, O. Kitao, H.
Nakai, M. Klene, X. Li, J.E. Knox, H.P. Hratchian, J.B. Cross, C. Adamo, J. Jaramillo,
R. Gomperts, R. E. Stratmann, O. Yazyev, A.J. Austin, R. Cammi, C. Pomelli, J.W.
Ochterski, P.Y. Ayala, K. Morokuma, G.A. Voth, P. Salvador, J.J. Dannenberg, V.G.
Zakrzewski, S. Dapprich, A.D. Daniels, M.C. Strain, O. Farkas, D.K. Malick, A.D.
Rabuck, K. Raghavachari, J.B. Foresman, J.V. Ortiz, Q. Cui, A.G. Baboul, S.
Clifford, J. Cioslowski, B.B. Stefanov, G. Liu, A. Liashenko, P. Piskorz, I.
Komaromi, R.L. Martin, D.J. Fox, T. Keith, M.A. Al-Laham, C.Y. Peng, A.
Nanayakkara, M. Challacombe, P.M.W. Gill, B. Johnson, W. Chen, M.W. Wong,
C. Gonzalez, J.A. Pople, Gaussian, Inc., Pittsburgh PA, 2003.
New 1,5-bis[(4-cyanophenyl)-N-methylamino]pentane (1) and
1,5-bis[(4-amidinophenyl)-N-methylamino]pentane dihydrochlo-
ride (2) have been characterized in solid-state, showing lack of
polymorphism. Single-crystal X-ray analysis showed that 1 crystal-
lizes in the orthorhombic space group P21212 and the asymmetric
unit contains one half of the ordered molecule. The crystal structure
of 1 is stabilized by intermolecular CAHꢃ ꢃ ꢃN hydrogen bond be-
tween the methyl and nitrile groups. Conformational analysis of 2
using NMR solid-state spectroscopy combined with DFT theoretical
computations has confirmed that NCH3 groups in aliphatic linker
has the alignment as in the crystal structure of 1, but its conforma-
tion is much more extended than that of bis-nitrile 1, and the dis-
tance from C1 to C10 is equal to 9.42 Å. In the present case, we
can suppose that the intermolecular hydrogen bonds are very weak.
New compounds 1 and 2 were synthesized with good yields by
an optimized procedure.
References
[1] D.T. Fisk, S. Meshick, P.H. Kazanjian, Clin. Infect. Dis. 36 (2003) 70–78.
[2] A. Morris, J.D. Lundgren, H. Masur, P.D. Walzer, D.L. Hanson, T. Frederick, L.
Huang, C.B. Beard, J.E. Kaplan, Emerg. Infect. Dis. 10 (2004) 713–720.
[3] D.A. Patrick, J.E. Hall, B.C. Bender, D.R. McCurdy, W.D. Wilson, F.A. Tanious, S.
Saba, R.R. Tidwell, Eur. J. Med. Chem. 34 (1999) 575–583.
[4] Y.A. Kuryshev, E. Ficker, L. Wang, P. Hawryluk, A.T. Denis, B.A. Wible, A.M.
Brown, J. kang, X.L. Chen, K. Sawamura, W. Reynolds, D. Rampe, J. Pharm. Exp.
Therap. 312 (2005) 316–323.
[19] C.F. Macrae, P.R. Edgington, P. McCabe, E. Pidcock, G.P. Shields, R. Taylor, M.
Towler, J. van de Streek, J. Appl. Cryst. 39 (2006) 453–457.
_
´
[20] D. Maciejewska, I. Wolska, J. Zabinski, J. Mol. Struct. 879 (2008) 53–59.